Trial
NCT00547118
The Effects of Rimonabant, on Weight and Metabolic Risk Factors
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Maryland, Baltimore
Collaborators
National Institute on Drug Abuse (NIDA)
Condition
Schizophrenia
Intervention
Rimonabant
Why stopped
Withdrawn due to medication withdrawal from the EMEA
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-11-04